Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Robert Nelsen

OTHER INVESTOR TYPE
9 INVESTMENTS
3 PORTFOLIO
2 EXITS
Description

Mr. Robert Nelsen is a Co-Founder and serves as a Managing Director at ARCH Venture Partners. He was a Board Member of Arivale. He is a Co-Founder and Board Member of Vir Biotechnology and Brii Biosciences. He is a Board Member of Encoded Therapeutics, Beam Therapeutics, Grail (Biotechnology) and Lyell. He is a Co-Founder and Board Member of Sana Biotechnology. He is also a Board Member of Agios Pharmaceuticals since December 2007. Additionally, he also served as an Advisor at Mighty AI. He is a Co-Founder of ARCH Venture Partners, a venture capital firm and has served in various capacities for ARCH and affiliated entities since 1986. He is currently a Managing Director of ARCH Venture Corporation. He has played a significant role in the early sourcing, financing and development of more than 30 companies. He served as Board Member at Ensemble Therapeutics. He is a Director of Sapphire Energy, Inc., Ensemble Therapeutics Corporation, Juno Therapeutics, Inc., Syros Pharmaceuticals Inc., Denali Therapeutics and Faraday Pharmaceuticals, Inc. among other companies. He previously served on the boards of Bellerophon Therapeutics, Inc., Fate Therapeutics, Inc., Elixir Pharmaceuticals, Inc., Ikaria Inc., Kythera Biopharmaceuticals, Inc., NeurogesX, Inc., Sage Therapeutics, Inc. and entities affiliated with deCode Genetics, Inc., among others. He was previously a Trustee of the Fred Hutchinson Cancer Research Institute, the Institute for Systems Biology and a director of the National Venture Capital Association. He received a B.S. with majors in biology and economics from the University of Puget Sound and an M.B.A. from the University of Chicago. He serves as Advisor at CityBldr

Primary Investor Type
Angel (individual)

Robert Nelsen Investments (9)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Gali (Elder and Disabled Care) 21-Jun-2019 Seed Round 00000 Elder and Disabled Care Generating Revenue 000000 000000
0000 (00000 000 00 01-Mar-2019 0000 00000 00.00 Elder and Disabled Care Generating Revenue 000000 000000
00000 02-Aug-2018 00000 00000 000.00 Other Consumer Durables Bankruptcy: Liquidation 000000 000000
0000000 000000 000 18-Jan-2018 00000 00000 0000 Consulting Services (B2B) Generating Revenue 000000 000000
0000000 000000 06-Dec-2016 00000 00000 0000 Biotechnology Generating Revenue 000000 000000
00000 24-May-2016 00000 00000 0000 Other Consumer Durables Bankruptcy: Liquidation 000000 000000
00000 20-Jan-2016 0000 00000 00.00 Other Consumer Durables Bankruptcy: Liquidation 000000 000000
Pioneer Square Labs 01-Oct-2015 Early Stage VC 000.00 Consulting Services (B2B) Generating Revenue 000000 000000
Mighty AI 08-Dec-2014 Seed Round 00.000 Road Generating Revenue 000000 000000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Robert Nelsen’s full profile, request a free trial.

Robert Nelsen Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
VICIS 31-Dec-2019 Bankruptcy: Liquidation Completed
000000 00 25-Jun-2019 000000000000000000 Completed
  • 0000
To view this investor’s complete exits history, request access »

Robert Nelsen Team (1)

Name Title Deals Funds Boards Office Contact
Info
Robert Nelsen Angel Investor 00 0 00 Seattle, WA